Le Lézard
Classified in: Health, Science and technology, Business
Subjects: EARNINGS, Conference Call, Webcast, Advisory

Aldeyra Therapeutics Schedules Webcast and Conference Call to Report Full-Year 2022 Financial Results and Discuss Recent Corporate Highlights


Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) will host a conference call at 8:00 a.m. ET Thursday, March 9, 2023 to report financial results for the year ended December 31, 2022 and discuss recent corporate highlights.

The dial-in numbers are (833) 470-1428 for domestic callers and (404) 975-4839 for international callers. The access code is 202679. A live audio webcast of the conference call also will be accessible from the "Investors & Media" section of Aldeyra's website at https://ir.aldeyra.com/.

After the live webcast, the event will remain archived on Aldeyra's website for 90 days.

About Aldeyra

Aldeyra Therapeutics is a clinical-stage biotechnology company developing innovative therapies designed to treat immune-mediated diseases. Our approach is to discover and develop pharmaceuticals that modulate immunological systems, instead of directly inhibiting or activating single protein targets, with the goal of optimizing multiple pathways at once while minimizing toxicity. Our product candidates include RASP (reactive aldehyde species) modulators ADX-629, ADX-246, ADX-248, and chemically related molecules for the potential treatment of systemic and retinal immune-mediated diseases. Our pre-commercial product candidates are reproxalap, a RASP modulator for the potential treatment of dry eye disease (under U.S. Food and Drug Administration New Drug Application review) and allergic conjunctivitis, and ADX-2191, a novel formulation of intravitreal methotrexate for the potential treatment of primary vitreoretinal lymphoma (under U.S. Food and Drug Administration New Drug Application review), proliferative vitreoretinopathy, and other rare sight-threatening retinal diseases. For more information, visit https://www.aldeyra.com/ and follow us on LinkedIn, Facebook, and Twitter.


These press releases may also interest you

at 11:30
Bringing the Clinic to You. Bringing the clinic to you!And now accepting private insurance plans! For even more access to the support your child needs. CloudSpeech is a private practice offering services online in Texas, California, and New York...

at 11:16
Imaraïs Beauty and The Vitamin Shoppe® announced today the launch of an assortment of new wellness gummies, formulated to support the health and wellness goals of beauty consumers, exclusively at The Vitamin Shoppe and Super Supplements stores and on...

at 11:13
Leading diagnostic and therapeutic medical technology company Laborie Medical Technologies Corp. (Laborie)?announced its investment in iO Urology, a venture-backed medical technology company that developed CarePath® an at-home, handheld uroflow...

at 11:04
Addressing the issue of employee wellness in healthcare, the American Association for Physician Leadership (AAPL) has published a new book, Working Happy! How to Survive Burnout and Find Your Work/Life Synergy in the Healthcare Industry. Author...

at 11:00
TDIndustries, a leading mechanical construction and facilities services firm, proudly announces that its Vice President of Environmental, Health and Safety Jamie Dabbs, CSP, ASP, CRIS, was named Construction Safety Professional of the Year by...

at 11:00
Nicklaus Children's Hospital this month attained Magnet recognition by the American Nurses Credentialing Center's Magnet Recognition Program® for the fifth consecutive term. Nicklaus Children's is one of only five children's hospitals in the nation...



News published on and distributed by: